Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-003242

EVP, CFO and COO sold 1,364 shares at $11.20 ($15,274)

From the SEC's structured data for this filing

Trades in this filing

Hyllengren Eric J · EVP, CFO and COO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-18 Sale : show line 1 in the form −1,364 $11.20 $15,274 23,392 D
Open-market sales · 1,364 sh · avg $11.20 · $15,274
Loading xslF345X05/form4.xml…